Eli Lilly Expects Up to $87 Billion in 2026 Revenue. Here's Why the Stock Still Looks Undervalued.

This pharma stock has climbed in the triple digits in recent years.

CryptoAlerta — análise de criptomoedas e mercado em tempo real